Stimwave Technologies and Aspen Medical Products Partner to Improve Patient Satisfaction Through Development of Wearable Pain Management Solutions | Business
POMPANO BEACH, Fla. and IRVINE, Calif.–(BUSINESS WIRE)–April 22, 2022–
Stimwave Technologies (Stimwave), the manufacturer of the Freedom Spinal Cord Stimulator (SCS) System, and Aspen Medical Products (Aspen), the industry leader in pain and mobility management solutions, today announced a collaboration to develop an innovative wearable pain management accessory for Stimwave patients with chronic pain.
“We are constantly looking for ways to improve the patient and physician experience with our therapies. The ability of a patient with chronic pain to actively participate in their care, alongside their doctor, is an essential element in improving their quality of life,” said Aure Bruneau, CEO of Stimwave. “Our HF-EMC power transfer technology provides us with a unique opportunity to combine our system with Aspen’s deep design experience trusted by millions of patients and clinicians for decades. Together, we can now deliver an improved, patient-specific solution. We are also committed to leading the development of additional treatment options that combine bracing and neuromodulation to deliver the next generation of chronic pain management.
Stimwave’s Freedom SCS platform is designed to treat chronic pain commonly associated with a patient’s back and legs by stimulating the nerves along their spine. Unlike other neurostimulation devices on the market, Stimwave’s Freedom SCS Therapy is wirelessly powered. To continue to improve the patient experience with the platform, Stimwave and Aspen have partnered to develop a portable device that comfortably and securely houses the systems external components. The new wearable can be worn under clothing, enabling streamlined, discreet and uninterrupted treatment.
“This partnership allows us to leverage the combined capabilities of Stimwave and Aspen into a sleek, concise system that helps chronic pain patients return to normal life faster,” commented Jim Cloar, CEO of Aspen. . “At the heart of everything we do is the need to play an important role in the puzzle of treating pain and improving lives. We are continuously focused on providing the highest quality products and solutions that help relieve pain and promote mobility. »
Clinicians are invited to visit the Stimwave booth (#303) or the Aspen booth (#404) at ASIPP (American Society of Interventional Pain Physicians) May 5-7, 2022 in Las Vegas to learn more. Additionally, please visit www.StimwaveFreedom.com to contact a representative.
Stimwave Technologies Incorporated is a privately-held medical device company engaged in the development, manufacturing and marketing of wireless-powered injectable microtechnology neurostimulators, providing patients with a convenient, safe, minimally invasive and highly cost-effective pain management solution that is easily incorporated into their daily lives. Stimwave’s goal is to evolve its industry-leading patented platform into neuromodulation by default, increasing accessibility for patients worldwide while reducing the economic impact of pain management. www.stimwavefreedom.com
About Aspen Medical Products
Founded in 1994, Aspen Medical Products, LLC is the industry leader in the development and manufacture of spinal orthopedic and pain treatment solutions. Designed to restore function and relieve pain, Aspen’s products address a variety of patient needs across the continuum of care to help them return to activities of daily living. Based in Irvine, CA, Aspen has local sales representation in the United States and internationally. www.aspenmp.com
See the source version on businesswire.com: https://www.businesswire.com/news/home/20220422005163/en/
KEYWORD: CALIFORNIA FLORIDA UNITED STATES NORTH AMERICA
INDUSTRY KEYWORD: BIOTECHNOLOGY GENERAL HEALTH MEDICAL DEVICES OTHER HEALTH HEALTH
SOURCE: Stimwave Technologies and Aspen Medical Products
Copyright BusinessWire 2022.
PUBLISHED: 04/22/2022 09:00 / DISK: 04/22/2022 09:02
Copyright BusinessWire 2022.